Furthermore, clinical studies have demonstrated that ANXA2 protein expression is associated with aggressive cancers, drug resistance, and radiotherapy resistance [19], suggesting that ANXA2 may be an oncogene that contributes to the malignant behavior of cancer cells. This evidence concerns the gene ANXA2 and cancer.